cervical-eng - Performance Monitoring for Cervical Cancer Screening Programs in Canada To promote and protect the health of Canadians through leadership

cervical-eng - Performance Monitoring for Cervical Cancer...

This preview shows page 1 - 9 out of 46 pages.

P ERFORMANCE M ONITORING FOR C ERVICAL C ANCER S CREENING P ROGRAMS IN C ANADA
To promote and protect the health of Canadians through leadership, partnership, innovation and action in public health. — Public Health Agency of Canada Performance Monitoring for Cervical Cancer Screening Programs in Canada is available on Internet at the following address: Également disponible en français sous le titre : Surveillance du rendement des programmes de dépistage du cancer du col utérin au Canada For additional copies of this report, please contact: Publications, Public Health Agency of Canada © Her Majesty the Queen in Right of Canada, 2009 Paper: Cat.: HP35-11/2009 PDF: Cat.: HP35-11/2009E-PDF ISBN: 978-0-662-06718-4 ISBN: 978-1-100-12423-0
P ERFORMANCE M ONITORING FOR C ERVICAL C ANCER S CREENING P ROGRAMS IN C ANADA J ANUARY 2009 Report from the Screening Performance Indicators Working Group, Cervical Cancer Prevention and Control Network (CCPCN) Collaboration with
T ABLE OF C ONTENTS A CKNOWLEDGMENTS ____________________________________________ 1 E XECUTIVE S UMMARY ___________________________________________ 2 B ACKGROUND _________________________________________________ 4 Introduction ........................................................................................................................ 4 Purpose .............................................................................................................................. 5 Organized Cervical Cancer Screening in Canada ................................................................. 5 History of Cervical Cancer Screening Program Performance Indicators in Canada ............... 6 Development of Performance Indicators ............................................................................... 6 Context of Performance Indicators ....................................................................................... 9 P ROGRAM P ERFORMANCE I NDICATORS ______________________________ 11 Coverage .......................................................................................................................... 12 1) Participation Rate .................................................................................................................... 12 2) Retention Rate ......................................................................................................................... 13 Cytology Performance Indicators ....................................................................................... 14 3) Specimen Adequacy ................................................................................................................ 14 4) Screening test results ............................................................................................................... 15 System Capacity Indicators ............................................................................................... 16 5) Cytology Turn Around Time ................................................................................................... 16 6) Time to Colposcopy ................................................................................................................. 17 Follow-up ......................................................................................................................... 18 7) Biopsy Rate .............................................................................................................................. 18 8) Cytology-Histology Agreement ............................................................................................... 19 Outcome Indicators .......................................................................................................... 20 9) Pre-Cancer Detection Rate ..................................................................................................... 20 10) Cancer Incidence ................................................................................................................... 21 11) Disease Extent at Diagnosis: Cancer Stage ........................................................................... 22 12) Screening History in Cases of Invasive Cancer ..................................................................... 23 F UTURE D IRECTIONS ___________________________________________ 24 A PPENDICES _________________________________________________ 27 Appendix A: CCPCN Performance Indicators Working Group Members (SPIWG) ......... 28 Appendix B: Components of an organized screening program ............................................ 29 Appendix C: History of Cervical Cancer Screening and the Development of Program Performance Indicators in Canada .................................................................................... 29 Appendix D: Glossary of Terms ........................................................................................ 31 R EFERENCES _________________________________________________ 34 Performance Monitoring for Cervical Cancer Screening Programs in Canada
1 Performance Monitoring for Cervical Cancer Screening Programs in Canada A CKNOWLEDGMENTS T he report, “Performance Monitoring for Cervical Cancer Screening Programs in Canada”, was prepared by the Screening Performance Indicators Working Group, Cervical Cancer Prevention and Control Network. The members are identified in Appendix A. This initiative would not have been possible without funding from the Public Health Agency of Canada.
Performance Monitoring for Cervical Cancer Screening Programs in Canada 2 E XECUTIVE S UMMARY • The purpose of this report is to define a core set of performance indicators for organized cervical cancer screening programs in Canada.

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture